Endovascular Recanalization for Symptomatic Chronic Intradural Occlusions

Recruiting Observational Study
Intracranial Stenosis Intracranial Atherosclerotic Disease
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
80 (estimated)
Sponsor
Insel Gruppe AG, University Hospital Bern · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Background: Chronic intracranial large vessel occlusion (LVO), resulting from progressive atherosclerosis or thrombosis, contributes significantly to ischemic strokes, 8-10% in North America and up to 50% in the Chinese population. This condition leads to cerebral hypoperfusion, brain ischemia, and potentially cognitive impairment. While extra-to-intracranial bypass surgery has shown limited benef…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * all consecutive patients who undergone endovascular recanalization for chronic intradural large vessel occlusions between January 1st, 2020, and December 31st, 2024 involving the following locations: internal carotid artery (ICA), middle cerebral artery (MCA), vertebral artery…
Contacts

Petra Cimflova, MD, PhD

+41316640831

petra.cimflova@insel.ch

CONTACT

Jan Gralla, Prof. Dr. med.

+41316322654

jan.gralla@insel.ch

CONTACT